Global Drug Eluting Stents (DES) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Drug Eluting Stents (DES) market size will reach 1,947.99 Million USD in 2025 and is projected to reach 3,198.29 Million USD by 2032, with a CAGR of 7.34% (2025-2032). Notably, the China Drug Eluting Stents (DES) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Drug-eluting stents (DES) are medical devices used in the treatment of coronary artery disease. They are tiny, wire mesh tubes that are implanted in narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty. What sets DES apart from traditional bare-metal stents is their coating with a medication, usually an anti-proliferative drug, that is slowly released over time. This drug helps inhibit the growth of cells that can lead to restenosis (re-narrowing) of the treated artery. By combining the mechanical support of the stent with the therapeutic effects of the drug, DES have significantly reduced the rate of restenosis compared to bare-metal stents. They play a crucial role in improving blood flow to the heart and reducing the need for repeat procedures in patients with coronary artery disease.

The major global  manufacturers of Drug Eluting Stents (DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen, Biosensors, Biotronik, Blue Medical, DISA Vascular, Boston Scientific, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Promed Medical, Orbusneich, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Drug Eluting Stents (DES). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Eluting Stents (DES) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Drug Eluting Stents (DES) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Eluting Stents (DES) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drug Eluting Stents (DES) Include:

Abbott Vascular

Advantec Vascular

B.Braun Melsengen

Biosensors

Biotronik

Blue Medical

DISA Vascular

Boston Scientific

Essen

Medtronic Vascular

MicroPort Medical

MIV Therapeutics

Promed Medical

Orbusneich

Relisys Medical

Reva Medical

Sahajanand

Sino Medical

Sorin

Drug Eluting Stents (DES) Product Segment Include:

Cobalt-chromium Alloy Stents

Magnesium Alloy Stents

Tyrosine Polycarbonate Stents

Nitinol Stents

Platinum Chromium Alloy Stents

Stainless Steel Stents

Other Materials

Drug Eluting Stents (DES) Product Application Include:

Coronary Artery Disease (CAD)

Acute Coronary Syndrome (ACS)

Stable Angina

Chronic Total Occlusion

Left Main Coronary Artery Disease

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Drug Eluting Stents (DES) Industry PESTEL Analysis

Chapter 3: Global Drug Eluting Stents (DES) Industry Porter's Five Forces Analysis

Chapter 4: Global Drug Eluting Stents (DES) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Drug Eluting Stents (DES) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Drug Eluting Stents (DES) Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Drug Eluting Stents (DES) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more